Phase 3 studies examining semaglutide specifically for NASH are ongoing
It was revealed that pretreatment with lixisenatide significantly suppressed elevation of inducible nitric oxide synthase (iNOS) and reversed the expression of endothelial nitric oxide synthase (eNOS) at the protein level and reduced mRNA of (NADPH oxidases 2) NOX2 in carotid arteries, which finally alleviated the endothelial dysfunction caused by ischemic/reperfusion (CI/R) in rats with diabetes more apparently than glimepiride (118)
And so when people say, Oh, this is just a cop-out, its an excuse, no, its not
Beysen, C., Karpe, F., Fielding, B., Clark, A., Levy, J., & Frayn, K
TB-500, a synthetic version related to thymosin beta-4 research, is commonly explored for cell migration, tissue remodeling, and recovery-related biological processes
Thus, interfering with these mechanisms and restricting amino acid access holds potential as an anticancer strategy 1